Search research articles
Contact Us
Filters
Showing results (891-900 of 1,172) with videos related to
Page
of 118
Sort By:
European Journal of Medicinal Chemistry
|
February 21, 2018
Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy
Chuantao Zha, Wenjia Deng, Yan Fu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Basic Science and Pathogenesis
Christopher T Brown, Jessica Enos, Carolyn Langlois, et al.
Retina (Philadelphia, Pa.)
|
February 18, 2025
INCIDENCE AND RISK FACTORS FOR PROGRESSION OF PACHYCHOROID DISEASE SPECTRUM
Angie Hon Chi Fong, Jinzhi Zhao, Wendy Meihua Wong, et al.
Cancer Immunology, Immunotherapy : CII
|
January 17, 2024
Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53
Brendan L C Kinney, Sreenivasulu Gunti, Vikash Kansal, et al.
Expert Opinion on Drug Safety
|
April 22, 2024
Efficacy and safety of bimekizumab in the treatment of psoriatic arthritis: a systematic review and meta-analysis
Qin-Yi Su, Liu Yang, Ting-Yu Cao, et al.
Acta Pharmacologica Sinica
|
September 15, 2017
SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models
Xi-Fei Jiang, Yang Dai, Xia Peng, et al.
Scientific Reports
|
June 9, 2021
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
Yen-Hsiang Huang, Jeng-Sen Tseng, Kuo-Hsuan Hsu, et al.
Advances in Therapy
|
August 12, 2022
Levels of Peripheral Th17 Cells and Th17-Related Cytokines in Patients with Ankylosing Spondylitis: A Meta-analysis
Qin-Yi Su, Jing-Wen Zheng, Jing-Yuan Yang, et al.
Targeted Oncology
|
April 23, 2022
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.
Journal of Alzheimer'S Disease : JAD
|
December 20, 2021
Studying APOE ɛ4 Allele Dose Effects with a Univariate Morphometry Biomarker
Gang Wang, Wenju Zhou, Deping Kong, et al.
Page
of 118
Search research articles
Search
Showing results (891-900 of 1,172) with videos related to
Sort By:
Page
of 118
European Journal of Medicinal Chemistry
|
February 21, 2018
Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy
Chuantao Zha, Wenjia Deng, Yan Fu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Basic Science and Pathogenesis
Christopher T Brown, Jessica Enos, Carolyn Langlois, et al.
Retina (Philadelphia, Pa.)
|
February 18, 2025
INCIDENCE AND RISK FACTORS FOR PROGRESSION OF PACHYCHOROID DISEASE SPECTRUM
Angie Hon Chi Fong, Jinzhi Zhao, Wendy Meihua Wong, et al.
Cancer Immunology, Immunotherapy : CII
|
January 17, 2024
Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53
Brendan L C Kinney, Sreenivasulu Gunti, Vikash Kansal, et al.
Expert Opinion on Drug Safety
|
April 22, 2024
Efficacy and safety of bimekizumab in the treatment of psoriatic arthritis: a systematic review and meta-analysis
Qin-Yi Su, Liu Yang, Ting-Yu Cao, et al.
Acta Pharmacologica Sinica
|
September 15, 2017
SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models
Xi-Fei Jiang, Yang Dai, Xia Peng, et al.
Scientific Reports
|
June 9, 2021
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
Yen-Hsiang Huang, Jeng-Sen Tseng, Kuo-Hsuan Hsu, et al.
Advances in Therapy
|
August 12, 2022
Levels of Peripheral Th17 Cells and Th17-Related Cytokines in Patients with Ankylosing Spondylitis: A Meta-analysis
Qin-Yi Su, Jing-Wen Zheng, Jing-Yuan Yang, et al.
Targeted Oncology
|
April 23, 2022
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.
Journal of Alzheimer'S Disease : JAD
|
December 20, 2021
Studying APOE ɛ4 Allele Dose Effects with a Univariate Morphometry Biomarker
Gang Wang, Wenju Zhou, Deping Kong, et al.
Page
of 118